Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study.
about
Epidemiology of arrhythmias and conduction disorders in older adultsRobotic magnetic navigation for ablation of human arrhythmiasThe current approach of atrial fibrillation managementKv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillationAnticoagulation in atrial fibrillationInhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cellsThe National Health Service, the universities, and the research councils: the future of academic medicineLone atrial fibrillation: where are we now?Secondhand smoke and atrial fibrillation: Data from the Health eHeart Study.Atrial Fibrillation: The New Epidemic of the Ageing WorldPrevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years.Long-term anticoagulation. Indications and management.Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillationIon channel trafficking: a new therapeutic horizon for atrial fibrillationP wave dispersion and QT dispersion in adult Turkish migrants with familial mediterranean fever living in Germany.Atrial fibrillation: current and future strategies for management.Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.Challenges in the classification of atrial fibrillation.Heart dysfunction in patients with acute ischemic stroke or TIA does not predict all-cause mortality at long-term follow-up.Warfarin cessation is non-essential in patients undergoing total knee arthroplasty--a case-control studyLack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillationAntithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation.Enlargement of the left atrium is associated with increased infiltration of immune cells in patients with atrial fibrillation who had undergone surgeryTransgenic insights linking pitx2 and atrial arrhythmiasSignificant Association Between CAV1 Variant rs3807989 on 7p31 and Atrial Fibrillation in a Chinese Han Population.Management decisions in lone atrial fibrillation.Long-term success and follow-up after atrial fibrillation ablation.Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review.X-linked nonsyndromic sinus node dysfunction and atrial fibrillation caused by emerin mutation.Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablationSynchronised cardioversion for chronic atrail fibrillation.Physician variation in the management of patients with atrial fibrillationComparison of CT in patients with cerebral ischaemia with or without non-rheumatic atrial fibrillation. European Atrial Fibrillation Trial and Dutch T I A Trial Study GroupsLone atrial fibrillation: influence of familial disease on gender predilectionAtrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown.Pharmacotherapy of atrial fibrillation: an old option with new possibilities.Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.Familial aggregation of atrial fibrillation: a study in Danish twins.
P2860
Q26830752-CF5B056F-F71D-4C28-9E9A-8763D487C895Q28075507-8EF62EE1-B8AB-4EC1-AAF5-4568948AF280Q28076171-60561F95-D00C-4305-BCAA-8B22664586B1Q28245803-28C9D927-16CF-444B-881A-195BBC59232BQ28315636-3CEA874D-BD6D-4650-BE72-BA6274F2842EQ28343255-FBF28BD6-8628-420E-A4A2-8729C0BCB7D5Q28763866-6D356E08-1AA6-4D2F-9FC7-7C116C437840Q30409016-2EC24B9B-61E0-4EC9-A1FE-FAC7DBE874BFQ30991603-338FA129-0361-4DB3-A4CF-B9E8749A955DQ33168630-A54C6292-0715-497B-B637-B3E1AC33352AQ33599340-511E4AF3-A24F-41E1-A727-B70A7AD9383EQ33617257-78866C36-C429-4D1B-ACB9-0D9549901024Q33617451-495B7894-72A0-4A49-ADA9-1D5F1C5F7A5AQ34101658-5620E754-6865-4273-A76F-3986670B8972Q34102054-0898969E-C58B-4190-B8FA-C67C27218059Q34126043-20241BD4-2618-4535-85C4-2930285B8376Q34181658-73313BFE-BEE3-44B0-8178-23DF8D64D98FQ34774724-BD8F152D-F990-4427-8824-6246A244CDC9Q34993257-1F060019-6ECC-42CF-BED7-74C6DED85012Q35041288-F58685A4-8D0F-40F7-BE0B-E7CE1914C82BQ35565932-88641B19-AAE1-4EFC-AAEC-43CDE273B571Q35752573-37985C3E-B858-4178-8E64-DF3B10F268C2Q35941124-A6F8A3B6-11AC-4AAC-8343-F6FCB6B6AC05Q35997420-21E4FC66-58D0-4A87-A1E2-B2FE7AA4162DQ36025564-5BF0AC8C-EE27-43EC-987A-07FB63758425Q36141457-DCDE7A35-31AB-46A6-8FE6-FD0FBAD071D9Q36172675-EC4D467A-6B09-472F-8401-C7F45CB9E46FQ36382385-F83C5594-286F-433E-AE02-39903A27D1E2Q36587229-EAECCA6E-1EF0-462F-9AC7-D5775819FD25Q36632036-740BA93B-ADE8-4DFF-A636-836B1E4F140CQ36654218-2E0BB2D2-0246-4281-A0EC-1E24F97B9B2FQ36711392-68DC987A-5E64-44C7-9E4F-FDCB692A3752Q36829595-7ADE149C-FAE9-4075-BCDA-5C07EB87B651Q36879446-C0690488-F374-43F7-B58D-A7764B6F375BQ36926402-4AD59565-F86F-4750-BB2A-9C01609FFD14Q37007410-8F332F5D-60A3-4862-A544-A5AB96AF3421Q37115731-EC415D54-3B46-47A0-8A03-E21439E8FC35Q37123391-087ACD8C-3940-4426-BFCE-47D417D18CDCQ37246263-27FA710A-4FC0-4740-AF4A-6FA52B49994BQ37382715-3F398687-45AB-49E3-B0F3-62B92D027259
P2860
Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study.
description
1985 nî lūn-bûn
@nan
1985 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Characteristics and prognosis ...... ow-up in the Framingham Study.
@ast
Characteristics and prognosis ...... ow-up in the Framingham Study.
@en
Characteristics and prognosis ...... ow-up in the Framingham Study.
@nl
type
label
Characteristics and prognosis ...... ow-up in the Framingham Study.
@ast
Characteristics and prognosis ...... ow-up in the Framingham Study.
@en
Characteristics and prognosis ...... ow-up in the Framingham Study.
@nl
prefLabel
Characteristics and prognosis ...... ow-up in the Framingham Study.
@ast
Characteristics and prognosis ...... ow-up in the Framingham Study.
@en
Characteristics and prognosis ...... ow-up in the Framingham Study.
@nl
P2093
P1476
Characteristics and prognosis ...... ow-up in the Framingham Study.
@en
P2093
P304
P356
10.1001/JAMA.1985.03360240061035
P407
P577
1985-12-01T00:00:00Z